NRXBF logo

NRXBF NurExone Biologic Inc.

Other OTC · Biotechnology · Healthcare

$0.35
-0.01 (-2.84%)

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. Its lead product, ExoPTEN, has demonstrated strong preclinical data supporting clinical potential in treating acute spinal cord and optic nerve injury. The company was founded on June 27, 2011 and is headquartered in …

Market Cap: $27.02Mwww.nurexone.com

Price

No data yet.

Social Signal Score

50
5d
50
1 mentions
—
30d
50
2 mentions
—
60d
50
2 mentions
—
90d
50
4 mentions
—
news: 4

Company Profile

CEO
Lior Shaltiel
Sector
Healthcare
Industry
Biotechnology
Employees
16
Beta
0.39
Country
CA
www.nurexone.com